An executive order allowing six states to import prescription drugs from Canada may not actually lower drug prices in the U.S, according to experts. The order, which takes effect late next month, doesn’t include biologics, such as insulin, nor any drugs available in Canada that haven’t been approved for use in the U.S. (Heathline)

The World Health Organization’s top emergency expert says about 10% of the world’s population has been infected with coronavirus. This leaves the vast majority of the world still at risk of contracting the disease. (Reuters)

Duke University is pioneering a new approach to developing clinical AI tools. This may make it easier for frontline healthcare workers to use. The effort involves researchers asking the workers themselves how to make these tools effective and helpful for them. (STAT)

India and South Africa have filed a request with the World Health Organization to waive intellectual property rules contained in a trade agreement. This would allow developing nations to more easily produce or import drugs to treat COVID-19. The countries said the rules can create an obstacle that prevents such countries from obtaining these medications quickly, in sufficient quantities and at an affordable price. (STAT)

The MM+M Awards take place virtually on Thursday, October 8. Join us for a night celebrating the best in healthcare marketing. (MM+M)